หน้าผลลัพธ์ 11 สำหรับ หมวดธุรกิจ: การดูแลสุขภาพ อุตสาหกรรม: เทคโนโลยีชีวภาพ ตลาดหุ้น - โควตและราคา
รายชื่อหุ้นและตราสารทุนทั้งหมดพร้อมราคา มูลค่าตามราคาตลาด PE และ EPS
ประเทศทั้งหมด
- {{country.name}}
- ประเทศทั้งหมด
- สหรัฐอเมริกา (1012)
- ออสเตรเลีย (58)
- ออสเตรีย (16)
- เบลเยียม (7)
- บราซิล (16)
- แคนาดา (83)
- จีน (94)
- เดนมาร์ก (6)
- ฟินแลนด์ (4)
- ฝรั่งเศส (41)
- เยอรมนี (738)
- ฮ่องกง (46)
- อินเดีย (19)
- ไอร์แลนด์ (1)
- อิสราเอล (19)
- อิตาลี (4)
- ญี่ปุ่น (37)
- เม็กซิโก (28)
- เนเธอร์แลนด์ (3)
- นิวซีแลนด์ (1)
- นอร์เวย์ (14)
- โปแลนด์ (9)
- รัสเซีย (2)
- เกาหลีใต้ (12)
- สเปน (4)
- สวีเดน (70)
- สวิตเซอร์แลนด์ (11)
- ไต้หวัน (67)
- ไทย (2)
- ตุรกี (1)
- สหราชอาณาจักร (69)
กระดานเทรดทั้งหมด
- {{item.name}}
- กระดานเทรดทั้งหมด
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
การดูแลสุขภาพ (2611)
- {{item.name}}
- หมวดธุรกิจทั้งหมด
- การดูแลสุขภาพ (2611)
เทคโนโลยีชีวภาพ (2611)
- {{item.name}}
- อุตสาหกรรมทั้งหมด
- เทคโนโลยีชีวภาพ (2611)
- ผู้ผลิตยา - ทั่วไป (279)
- ผู้ผลิตยา - เฉพาะทางและทั่วไป (1705)
- แผนการดูแลสุขภาพ (57)
- สิ่งอำนวยความสะดวกการดูแลทางการแพทย์ (553)
- ผู้ค้าปลีกเภสัชภัณฑ์ (155)
- บริการข้อมูลด้านสุขภาพ (419)
- อุปกรณ์ทางการแพทย์ (913)
- เครื่องมือและอุปกรณ์ทางการแพทย์ (501)
- การวินิจฉัยและการวิจัย (427)
- การจำหน่ายทางการแพทย์ (138)
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS |
|---|
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Neovacs S.A. ALNEV.PA | $0.005 0.0054 USD |
+4.17
|
$10.35K 11.31K USD | $45.05M 49.25M USD | $0.004199 0.0045 USD | $0.006599 0.0072 USD | $10.35K 11.31K USD | 0 | -$221.3 -241.9 USD | |
| Statera Biopharma STAB | $0.0001 — |
0
|
$7.14K — | $2.1K — | $0.0001 — | $0.0001 — | $7.14K — | 0 | -$2.36 — | |
| Better Therapeutics BTTX | $0.0001 — |
0
|
$5.45K — | $500 — | $0.0001 — | $0.0001 — | $5.45K — | 0 | -$1.1 — | |
| NLS Pharmaceutics NLSPW | $0.01 — |
+10.24
|
$0 — | $58.78K — | $0.01 — | $0.02 — | $0 — | 0 | $0 — | |
| Novo Nordisk A/S N1VO34.SA | $48.09 9.75 USD |
-0.64
|
$1.71T 346.48B USD | $13.37K 2.71K USD | $47.31 9.59 USD | $48.39 9.81 USD | $1.71T 346.48B USD | 18.93 | $2.54 0.51 USD | |
| Novo Nordisk A/S NOVA.F | $59.8 65.37 USD |
-0.66
|
$263.83B 288.41B USD | $1.05K 1.15K USD | $57.8 63.18 USD | $61.7 67.45 USD | $263.83B 288.41B USD | 18.98 | $3.15 3.44 USD | |
| Novo Nordisk A/S NVON.MX | $1,294 76.62 USD |
-1.82
|
$2.98T 176.7B USD | $2.36K 139.98 USD | $1,282.73 75.95 USD | $1,323.81 78.39 USD | $2.98T 176.7B USD | 20.84 | $62.09 3.68 USD | |
| Vertex Pharmaceuticals Incorporated VRTX34.SA | $614.08 124.46 USD |
+0.82
|
$640.34B 129.79B USD | $66 13.38 USD | $614.08 124.46 USD | $617.77 125.21 USD | $640.34B 129.79B USD | 0 | -$5.47 -1.1 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.MX | $8,350 494.42 USD |
-2.99
|
$2.16T 128.14B USD | $88 5.21 USD | $8,350 494.42 USD | $8,350 494.42 USD | $2.16T 128.14B USD | 0 | -$73.48 -4.3 USD | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $383.25 418.94 USD |
-0.04
|
$99.25B 108.5B USD | $1 1.09 USD | $379.15 414.46 USD | $383.25 418.94 USD | $99.25B 108.5B USD | 0 | -$3.37 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $383 418.67 USD |
+0.04
|
$99.25B 108.5B USD | $14 15.3 USD | $383 418.67 USD | $383.3 419 USD | $99.25B 108.5B USD | 0 | -$3.37 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.DE | $383.45 419.16 USD |
-0.22
|
$99.25B 108.49B USD | $227 248.14 USD | $379.2 414.52 USD | $383.85 419.6 USD | $99.25B 108.49B USD | 0 | -$3.37 -3.6 USD | |
| CSL CMXHF | $164.51 — |
0
|
$79.66B — | $200 — | $151.25 — | $151.25 — | $79.66B — | 30.18 | $5.45 — | |
| CSL Limited CSJA.F | $69 75.43 USD |
+0.73
|
$67.78B 74.09B USD | $5 5.47 USD | $68.5 74.88 USD | $69 75.43 USD | $67.78B 74.09B USD | 28.51 | $2.42 2.65 USD | |
| CSL Limited CSJ.F | $138 150.85 USD |
-0.72
|
$67.78B 74.09B USD | $10 10.93 USD | $138 150.85 USD | $138 150.85 USD | $67.78B 74.09B USD | 28.57 | $4.83 5.28 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $55.32 11.21 USD |
-1.71
|
$363.29B 73.63B USD | $523 106 USD | $55.32 11.21 USD | $56.16 11.38 USD | $363.29B 73.63B USD | 14.75 | $3.75 0.76 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $11,620.03 688.05 USD |
0
|
$1.23T 73.03B USD | $0 0 USD | $11,620.03 688.05 USD | $11,620.03 688.05 USD | $1.23T 73.03B USD | 15.29 | $759.95 45 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $517.2 565.37 USD |
-1.71
|
$56.31B 61.55B USD | $0 0 USD | $517.2 565.37 USD | $528.4 577.61 USD | $56.31B 61.55B USD | 14.90 | $34.7 37.93 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,016,000 766.91 USD |
-5.93
|
$72.31T 54.58B USD | $108.59K 81.97 USD | $1,016,000 766.91 USD | $1,084,000 818.24 USD | $72.31T 54.58B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $82.54 16.73 USD |
0
|
$216.23B 43.83B USD | $0 0 USD | $82.54 16.73 USD | $82.54 16.73 USD | $216.23B 43.83B USD | 0 | -$0.6 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $131.95 26.74 USD |
+0.3
|
$202.72B 41.09B USD | $2 0.41 USD | $131.95 26.74 USD | $132.08 26.77 USD | $202.72B 41.09B USD | 35.18 | $3.75 0.76 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $252.2 275.69 USD |
-1.33
|
$33.51B 36.64B USD | $10 10.93 USD | $252.2 275.69 USD | $252.2 275.69 USD | $33.51B 36.64B USD | 0 | -$1.87 -2.04 USD | |
| argenx SE ARGNF | $562 — |
0
|
$35.73B — | $10 — | $562 — | $562 — | $35.73B — | 34.24 | $16.41 — | |
| UCB SA UCBJF | $175.75 — |
0
|
$34.56B — | $100 — | $174.55 — | $174.55 — | $34.56B — | 28.34 | $6.2 — | |
| argenx SE 1AE.F | $515 562.96 USD |
+0.35
|
$31.45B 34.37B USD | $2 2.19 USD | $512.8 560.56 USD | $515 562.96 USD | $31.45B 34.37B USD | 35.46 | $14.52 15.87 USD | |
| argenx SE ARGX.VI | $509.8 557.28 USD |
-0.82
|
$31.42B 34.35B USD | $0 0 USD | $509.8 557.28 USD | $519.8 568.21 USD | $31.42B 34.35B USD | 35.20 | $14.48 15.83 USD | |
| argenx SE 1AEA.F | $505 552.03 USD |
-0.98
|
$31.42B 34.35B USD | $9 9.84 USD | $505 552.03 USD | $505 552.03 USD | $31.42B 34.35B USD | 34.73 | $14.54 15.89 USD | |
| UCB SA UNC0.F | $79 86.36 USD |
-1.25
|
$30.03B 32.82B USD | $50 54.66 USD | $79 86.36 USD | $79 86.36 USD | $30.03B 32.82B USD | 28.83 | $2.74 3 USD | |
| UCB SA UCB.VI | $153.8 168.12 USD |
-3.66
|
$29.43B 32.17B USD | $239 261.26 USD | $153.8 168.12 USD | $161.45 176.49 USD | $29.43B 32.17B USD | 28.06 | $5.48 5.99 USD | |
| UCB SA UNC.F | $153.55 167.85 USD |
-5.36
|
$29.43B 32.17B USD | $18 19.68 USD | $153.55 167.85 USD | $160.7 175.67 USD | $29.43B 32.17B USD | 28.02 | $5.48 5.99 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BioNTech SE B1NT34.SA | $34.84 7.06 USD |
+1.78
|
$135.67B 27.5B USD | $255 51.68 USD | $34.24 6.94 USD | $34.84 7.06 USD | $135.67B 27.5B USD | 0 | -$1.29 -0.2 USD | |
| BeiGene, Ltd. 49B.F | $15.99 17.47 USD |
+1.62
|
$24.56B 26.85B USD | $119 130.08 USD | $15.99 17.47 USD | $15.99 17.47 USD | $24.56B 26.85B USD | 0 | -$0.25 -0.2 USD | |
| BeiGene, Ltd. 49BA.F | $214 233.93 USD |
0
|
$24.56B 26.85B USD | $5 5.47 USD | $214 233.93 USD | $214 233.93 USD | $24.56B 26.85B USD | 0 | -$3.23 -3.5 USD | |
| BioNTech SE 0A3M.IL | $97.25 — |
-0.77
|
$26.75B — | $826 — | $96.45 — | $98.2 — | $26.75B — | 5.40 | $18 — | |
| Celltrion, Inc. 068270.KS | $152,700 115.26 USD |
-0.52
|
$33.24T 25.09B USD | $398.15K 300.54 USD | $151,500 114.36 USD | $154,100 116.32 USD | $33.24T 25.09B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BioNTech SE BNTX.VI | $85.9 93.9 USD |
-1.43
|
$21.03B 22.99B USD | $230 251.42 USD | $85.5 93.46 USD | $87.45 95.59 USD | $21.03B 22.99B USD | 0 | -$3.19 -3.4 USD | |
| BioNTech SE 22UA.F | $86.7 94.77 USD |
-2.36
|
$21.03B 22.99B USD | $45 49.19 USD | $84.85 92.75 USD | $87.65 95.81 USD | $21.03B 22.99B USD | 0 | -$3.19 -3.4 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.MU | $28.83 31.52 USD |
-1.5
|
$16.17B 17.68B USD | $0 0 USD | $28.83 31.52 USD | $28.83 31.52 USD | $16.17B 17.68B USD | 13.28 | $2.17 2.37 USD | |
| Royalty Pharma plc RPD.F | $28.22 30.85 USD |
-2.69
|
$16.17B 17.68B USD | $85 92.92 USD | $28.22 30.85 USD | $28.27 30.9 USD | $16.17B 17.68B USD | 13.00 | $2.17 2.37 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.33 | $52.24 3.09 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Incyte Corporation I1NC34.SA | $171.27 34.71 USD |
0
|
$71.12B 14.42B USD | $0 0 USD | $171.27 34.71 USD | $171.27 34.71 USD | $71.12B 14.42B USD | 300.47 | $0.57 0.12 USD | |
| Incyte Corporation INCY.MX | $1,180.69 69.91 USD |
0
|
$240.36B 14.23B USD | $0 0 USD | $1,180.69 69.91 USD | $1,180.69 69.91 USD | $240.36B 14.23B USD | 302.74 | $3.9 0.23 USD | |
| United Therapeutics Corporation UTH.F | $270.2 295.37 USD |
-0.63
|
$12.3B 13.45B USD | $70 76.52 USD | $270.2 295.37 USD | $270.2 295.37 USD | $12.3B 13.45B USD | 12.14 | $22.24 24.31 USD | |
| Genmab A/S GNMSF | $208.35 — |
0
|
$12.85B — | $1 — | $196.2 — | $196.2 — | $12.85B — | 12.22 | $17.04 — | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $164.7 33.38 USD |
0
|
$63.17B 12.8B USD | $0 0 USD | $164.7 33.38 USD | $164.7 33.38 USD | $63.17B 12.8B USD | 21.33 | $7.72 1.56 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| WuXi Biologics (Cayman) WXIBF | $3 — |
0
|
$12.38B — | $1K — | $3 — | $3 — | $12.38B — | 27.27 | $0.11 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Genmab A/S GMAB.VI | $183.4 200.48 USD |
-1.87
|
$11.31B 12.37B USD | $0 0 USD | $181.8 198.73 USD | $190.1 207.8 USD | $11.31B 12.37B USD | 12.19 | $15.04 16.44 USD | |
| Innovent Biologics IVBXF | $7.39 — |
+34.61
|
$12.26B — | $200 — | $7.24 — | $7.39 — | $12.26B — | 0 | -$0.01 — | |
| Incyte Corporation ICY.F | $56.72 62 USD |
-0.28
|
$11.02B 12.05B USD | $22 24.05 USD | $56.72 62 USD | $56.72 62 USD | $11.02B 12.05B USD | 315.11 | $0.18 0.2 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.25 5.74 USD |
-2.78
|
$10.98B 12B USD | $10 10.93 USD | $5.25 5.74 USD | $5.25 5.74 USD | $10.98B 12B USD | 27.63 | $0.19 0.21 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.67 2.92 USD |
-1.78
|
$10.98B 12B USD | $1K 1.09K USD | $2.65 2.9 USD | $2.67 2.92 USD | $10.98B 12B USD | 26.69 | $0.1 0.11 USD | |
| Insmed Incorporated IM8N.SG | $59 64.49 USD |
+1.72
|
$10.9B 11.92B USD | $0 0 USD | $58.5 63.95 USD | $59 64.49 USD | $10.9B 11.92B USD | 0 | -$5.26 -5.7 USD | |
| Insmed Incorporated IM8N.F | $59.5 65.04 USD |
+2.59
|
$10.9B 11.92B USD | $10 10.93 USD | $58 63.4 USD | $59.5 65.04 USD | $10.9B 11.92B USD | 0 | -$5.25 -5.7 USD | |
| Innovent Biologics, Inc. 6IB.F | $6.55 7.16 USD |
+3.97
|
$10.87B 11.88B USD | $200 218.63 USD | $6.55 7.16 USD | $6.6 7.21 USD | $10.87B 11.88B USD | 0 | -$0.01 -0.01 USD | |
| Moderna, Inc. MRNA.MX | $502 29.72 USD |
-2.82
|
$196.29B 11.62B USD | $1.52K 89.88 USD | $494 29.25 USD | $504.02 29.84 USD | $196.29B 11.62B USD | 0 | -$168.7 -9.9 USD | |
| Ascendis Pharma A/S A1SN34.SA | $59.46 12.05 USD |
0
|
$56.01B 11.35B USD | $0 0 USD | $59.46 12.05 USD | $59.46 12.05 USD | $56.01B 11.35B USD | 0 | -$37.47 -7.5 USD | |
| Exelixis, Inc. EX9.F | $37.45 40.94 USD |
-2.04
|
$10.25B 11.2B USD | $741 810.01 USD | $37.45 40.94 USD | $37.45 40.94 USD | $10.25B 11.2B USD | 19.30 | $1.94 2.12 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $50.94 55.68 USD |
-0.82
|
$9.78B 10.69B USD | $652 712.72 USD | $50.94 55.68 USD | $50.94 55.68 USD | $9.78B 10.69B USD | 21.31 | $2.39 2.61 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $50.68 55.4 USD |
-1.32
|
$9.78B 10.69B USD | $0 0 USD | $50.68 55.4 USD | $51.22 55.99 USD | $9.78B 10.69B USD | 21.29 | $2.38 2.6 USD | |
| Moderna, Inc. 0QF.MU | $23.89 26.11 USD |
+5.31
|
$9.24B 10.1B USD | $50 54.66 USD | $23.56 25.75 USD | $23.89 26.11 USD | $9.24B 10.1B USD | 0 | -$7.74 -8.4 USD | |
| Moderna, Inc. MRNA.VI | $22.7 24.81 USD |
-1.99
|
$9B 9.84B USD | $1.04K 1.14K USD | $22.7 24.81 USD | $23.91 26.14 USD | $9B 9.84B USD | 0 | -$7.7 -8.4 USD | |
| Moderna, Inc. 0QF.F | $22.93 25.06 USD |
-1.76
|
$9B 9.84B USD | $810 885.44 USD | $22.93 25.06 USD | $23.25 25.42 USD | $9B 9.84B USD | 0 | -$7.74 -8.4 USD | |
| Verona Pharma plc I9SA.F | $65.6 71.71 USD |
+0.31
|
$8.86B 9.69B USD | $5.04K 5.51K USD | $61.8 67.56 USD | $65.6 71.71 USD | $8.86B 9.69B USD | 0 | -$1.77 -1.9 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.5 — |
0
|
$9.55B — | $2.5K — | $0.45 — | $0.45 — | $9.55B — | 49.50 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $9.48 — |
0
|
$9.55B — | $44 — | $9.75 — | $9.75 — | $9.55B — | 32.68 | $0.29 — | |
| Ascendis Pharma A/S A71.F | $140 153.04 USD |
+0.72
|
$8.68B 9.49B USD | $20 21.86 USD | $140 153.04 USD | $140 153.04 USD | $8.68B 9.49B USD | 0 | -$5.81 -6.3 USD | |
| Akeso, Inc. 4RY.F | $9.2 10.06 USD |
-3.66
|
$8.45B 9.24B USD | $251 274.38 USD | $9.2 10.06 USD | $9.3 10.17 USD | $8.45B 9.24B USD | 0 | -$0.07 -0.07 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Bio-Techne Corporation TECH.MX | $914.35 54.14 USD |
0
|
$145.28B 8.6B USD | $0 0 USD | $0 0 USD | $0 0 USD | $145.28B 8.6B USD | 35.99 | $25.4 1.5 USD | |
| Bio-Techne Corporation T1CH34.SA | $8.92 1.81 USD |
-0.34
|
$41.95B 8.5B USD | $2 0.41 USD | $8.92 1.81 USD | $8.92 1.81 USD | $41.95B 8.5B USD | 55.75 | $0.16 0.03 USD | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Corcept Therapeutics Incorporated HTD.F | $69.14 75.58 USD |
+2.4
|
$7.4B 8.09B USD | $10 10.93 USD | $66.44 72.63 USD | $69.14 75.58 USD | $7.4B 8.09B USD | 67.78 | $1.02 1.11 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,017.5 60.25 USD |
0
|
$129.89B 7.69B USD | $0 0 USD | $1,017.5 60.25 USD | $1,017.5 60.25 USD | $129.89B 7.69B USD | 14.00 | $72.65 4.3 USD | |
| Roivant Sciences Ltd. 87S.F | $9.29 10.16 USD |
-0.85
|
$6.88B 7.52B USD | $600 655.88 USD | $9.29 10.16 USD | $9.55 10.44 USD | $6.88B 7.52B USD | 0 | -$0.89 -0.9 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Revolution Medicines, Inc. 42Z.F | $34 37.17 USD |
+0.59
|
$6.57B 7.18B USD | $30 32.79 USD | $34 37.17 USD | $34 37.17 USD | $6.57B 7.18B USD | 0 | -$3.56 -3.8 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $19.1 20.88 USD |
-3.29
|
$6.54B 7.15B USD | $450 491.91 USD | $19.1 20.88 USD | $19.2 20.99 USD | $6.54B 7.15B USD | 0 | -$4.47 -4.8 USD | |
| Bio-Techne Corporation TE1.F | $40.8 44.6 USD |
-1.92
|
$6.5B 7.11B USD | $114 124.62 USD | $40.8 44.6 USD | $41 44.82 USD | $6.5B 7.11B USD | 55.89 | $0.73 0.8 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $47.19 51.59 USD |
-0.72
|
$5.96B 6.51B USD | $60 65.59 USD | $47.19 51.59 USD | $47.29 51.69 USD | $5.96B 6.51B USD | 14.17 | $3.33 3.64 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $94.78 103.61 USD |
-1
|
$5.9B 6.45B USD | $1 1.09 USD | $93.84 102.58 USD | $95.68 104.59 USD | $5.9B 6.45B USD | 14.53 | $6.52 7.13 USD | |
| Blueprint Medicines Corporation 2L9.F | $86.78 94.86 USD |
-1.41
|
$5.81B 6.35B USD | $50 54.66 USD | $86.78 94.86 USD | $87.94 96.13 USD | $5.81B 6.35B USD | 0 | -$2.22 -2.4 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $28.96 31.66 USD |
+1.01
|
$5.61B 6.13B USD | $100 109.31 USD | $28.96 31.66 USD | $28.96 31.66 USD | $5.61B 6.13B USD | 0 | -$3.16 -3.4 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$102.98B 6.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $102.98B 6.1B USD | 0 | -$57.78 -3.4 USD | |
| Financière de Tubize SA FTD.F | $125 136.64 USD |
-0.64
|
$5.56B 6.08B USD | $70 76.52 USD | $125 136.64 USD | $125 136.64 USD | $5.56B 6.08B USD | 61.57 | $2.03 2.22 USD | |
| Financière de Tubize SA FTD.SG | $121.4 132.71 USD |
-3.5
|
$5.45B 5.96B USD | $0 0 USD | $121.4 132.71 USD | $125 136.64 USD | $5.45B 5.96B USD | 59.80 | $2.03 2.22 USD | |
| 3SBio Inc. 83B.F | $2.18 2.38 USD |
0
|
$5.35B 5.85B USD | $1.89K 2.06K USD | $2.18 2.38 USD | $2.24 2.45 USD | $5.35B 5.85B USD | 21.80 | $0.1 0.11 USD | |
| ALK-Abelló A/S AKBLF | $25.95 — |
0
|
$5.81B — | $100 — | $22.35 — | $22.35 — | $5.81B — | 40.54 | $0.64 — | |
|
ไม่มีหุ้นที่ชื่นชอบ
คุณยังไม่มีหุ้นที่ชื่นชอบ กรุณาเพิ่มลงในรายการโปรดเพื่อดูที่นี่ |
||||||||||